Abstract
This completed Frost & Sullivan research consists of 3 titles: Competing for
CRO Business in Japan, S Korea, Australia: What Pharmaceutical and
Biotechnology Companies Want. Competing for Domestic CRO Business in China:
What Pharmaceutical and Biotechnology Companies Want and Competing fro CRO
Business in India: What Pharmaceutical and Biotechnology Companies Want. Each
of them provides an understanding of the key motivations for companies to
outsource drug development and the benefits that they seek and experience from
outsourcing. The criteria that pharmaceutical and biotechnology companies use
to select their CRO partners are also highlighted. This would help CROs that
already operate in these markets, or those that plan to start operations in
them, to fine tune/develop strategies to achieve enhanced competitiveness.
This analysis is available through our Pharmaceuticals & Biotechnology Growth
Partnership Service program. With this program, clients receive
industry-leading market research such as this, along with technical and
econometric data and many interactive features including Analyst Inquiry Time
and Client Council.
| 
View Cart
